إعلان
إعلان
VERA
Vera Therapeutics, Inc. Class A Common Stock
48.61
USDبرعاية
-2.03
-4.01%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
49.63
+1.02
+2.11%
تقارير أرباح VERA
النسبة الإيجابية المفاجئة
VERA تفوق 6 من 19 آخر التقديرات.
32%
التقرير التالي
بيانات التقرير القادم
٢٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$1.30
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/+3.17%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/+80.56%
Vera Therapeutics, Inc. Class A Common Stock earnings per share and revenue
On ٠٥ نوفمبر ٢٠٢٥, VERA reported earnings of -1.26 USD per share (EPS) for Q3 25, missing the estimate of -1.15 USD, resulting in a -8.76% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analysts forecast an EPS of -1.30 USD, with revenue projected to reach -- USD, implying an increase of 3.17% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Vera Therapeutics, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Vera Therapeutics, Inc. Class A Common Stock reported EPS of -$1.26, missing estimates by -8.76%, and revenue of $0.00, 0% as expectations.
How did the market react to Vera Therapeutics, Inc. Class A Common Stock's Q3 2025 earnings?
The stock price moved down -1.03%, changed from $24.35 before the earnings release to $24.10 the day after.
When is Vera Therapeutics, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for ٢٤ فبراير ٢٠٢٦.
What are the forecasts for Vera Therapeutics, Inc. Class A Common Stock's next earnings report?
Based on 14
analysts, Vera Therapeutics, Inc. Class A Common Stock is expected to report EPS of -$1.30 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان